Respiratory syncytial virus vaccine
Vaccine against respiratory syncytial virus
📊 Rating
1 news mentions · 👍 0 likes · 👎 0 dislikes
📌 Topics
- Pharmaceuticals (1)
- Public Health (1)
- Global Trade (1)
🏷️ Keywords
GSK (1) · Arexvy (1) · RSV vaccine (1) · China NMPA (1) · Infectious diseases (1) · Healthcare regulation (1) · Elderly care (1)
📖 Key Information
A respiratory syncytial virus vaccine, or RSV vaccine, is a vaccine that protects against respiratory syncytial virus. RSV affects an estimated 64 million people and causes 160,000 deaths worldwide each year.
The RSV vaccines Arexvy (GSK), Abrysvo (Pfizer), and Mresvia (Moderna) are approved for medical use in the United States.
📰 Related News (1)
🔗 Entity Intersection Graph
People and organizations frequently mentioned alongside Respiratory syncytial virus vaccine: